logo for Telix

Telix

Manufacturing · Australia · 234 Employees

View Company Info for Free

About

Headquarters

55 Flemington Rd Ste 401, North Melbourne, Vict...

Phone Number

+61 330933897

Revenue

$328.9 Million

Stock Symbol

TLX

Industry

Pharmaceuticals Healthcare

Highlights

$25M

Total Funding Amount

$25M

Most Recent Funding Amount

1

Number of Funding Rounds

Who is Telix

Telix Pharmaceuticals, established in 2018 and headquartered in North Melbourne, Australia, is a radiopharmaceutical company, develops molecularlytargeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the United States.Read more

Telix's Social MediaPopular Searchestelix pharmaceuticals LtdTelix IncTelix PharmaceuticalsTelixTelix Industries IncSIC Code 28,283NAICS Code 32,325Ticker ASX: TLXShow more

Telix Org Chart

David Cade

Chief Executive Officer, Telix (Asia Pacific)

PhoneEmail
Darren Patti

Group Chief Operating Officer

PhoneEmail
Darren Smith

Group Chief Financial Officer

PhoneEmail

PhoneEmail

Similar Companies to Telix

Telix Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateNov 02, 2020
RoundCorporate Investment
Amount$25M
InvestorsChina Grand Pharmaceutical and Healthcare Holdings Ltd.
See More

$25M

Total Funding Amount

$25M

Most Recent Funding Amount

1

Number of Funding Rounds

Acquisitions & Subsidiaries

Sep 03, 2021

QSAM Biosciences

Jan 24, 2018

ARTMS

Feb 23, 2014

Lightpoint Medical

Sep 17, 2013

ATLAB Pharma SAS

Nov 20, 2009

IsoTherapeutics Group

Dedicaid

See More Acquisitions & Subsidiaries

Telix Tech Stack

Top Companies in Australia

Top 10 companies in Australia by revenue

Top 10 companies in Australia by number of employees

Top 10 companies in Australia by total funding amount

See top companies

Telix News & Media

  • Q1 2024 Revenue and Business Update

    MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 31 March 2024 (Q1 2024).
  • Q1 2024 Revenue and Business Update

    MELBOURNE, Australia, April 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 31 March 2024 (Q1 2024). Summary: Q1 2024 financial performance The Company reports unaudited total revenue of US$114.9M[1] (AU$175.0M) an increase of 18% on the prior quarter (US$97.1M[2] or AU$148.1M). Revenue was primarily generated from sales of Telix's prostate cancer imaging product Illucc
  • TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation

    FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging Collaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as commercial manufacturing and pharmacy distribution partner MELBOURNE, Australia, April 16, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation[1] for the Com
  • TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation

    MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation1 for the Company’s investigational glioma imaging product, TLX101-CDx (Pixclara™2, 18F-floretyrosine or 18F-FET).
  • Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.

    BURNABY, British Columbia--(BUSINESS WIRE)--ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed. This acquisition further enhances the vertical integration of Telix’s supply chain and manufacturing by providing a greater level of supply chain and regulatory control over the production of key isotopes. ARTMS will support the high efficiency, large-scale and cost-effective production of commercially important medical isotopes
Read more news

Frequently Asked Questions regarding Telix

Where is Telix located?
Telix's headquarters are located at 55 Flemington Rd Ste 401, North Melbourne, Victoria, 3051, Australia
What is Telix's phone number?
Telix's phone number is +61 330933897
What is Telix's stock symbol?
Telix's stock symbol is TLX
What is Telix's official website?
Telix's official website is www.telixpharma.com
What is Telix's Revenue?
Telix's revenue is $328.9 Million
What is Telix's SIC code?
Telix's SIC: 28,283
What is Telix's NAICS code?
Telix's NAICS: 32,325
How many employees does Telix have?
Telix has 234 employees
What industry does Telix belong to?
Telix is in the industry of: Pharmaceuticals, Healthcare
What is Telix competition?
Telix top competitors include: Antengene Corp, George Clinical Pty Ltd, Nucleus Network Pty Ltd, Novotech Ltd
What companies has Telix acquired?
Telix has acquired the companies: QSAM Biosciences, ARTMS, Lightpoint Medical, ATLAB Pharma SAS
What technology does Telix use?
Some of the popular technologies that Telix uses are: iMedidata, Microsoft SharePoint, reCAPTCHA v2.0, Smartsheet
Who is the CEO of Telix?
Telix's CEO is Kevin Richardson
Who is the CFO of Telix?
Telix's CFO is Harry Marfatia
How do I contact Telix?
Telix contact info: Phone number: +61 330933897 Website: www.telixpharma.com
What does Telix do?

Telix Pharmaceuticals, established in 2018 and headquartered in North Melbourne, Australia, is a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the United States.... Read More

What are Telix social media links?
Telix Linkedin page Telix Twitter page Telix Facebook page
How much funding has Telix raised to date?
Telix has raised $25 Million in 1 funding round
When was the last funding round for Telix?
Telix closed its last funding round on Nov 02, 2020 with the amount of $25 Million
Is Telix a public company?
Yes, Telix is a public company and is traded under the symbol TLX
See more information about Telix

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.